Key takeaways:

The WHO added adalimumab and ustekinumab for moderate to severe psoriasis to its Essential Medicines List.

The committee also added high broad-spectrum sunscreen for people with albinism.

The WHO added the biologics adalimumab and ustekinumab for psoriasis, sunscreen for people with albinism and urea- and glycerol-based moisturizers to the 2025 update of its Model List of Essential Medicines, according to a press release.

The news was announced by the International League of Dermatological Societies (ILDS) following its applications to WHO, with the support of other councils and societies, to add these medicines to the updated list, part of a larger effort to address the health of underserved populations. The biologics Humira ( adalimumab , Abbvie) and Stelara ( ustek

See Full Page